BetterScholar BetterScholar

M. Pencina

15
Role
Title
Level Year L/R
🐜 General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
7 auth. R. D'Agostino, R. Vasan, M. Pencina, P. Wolf, M. Cobain, J. Massaro, ... W. Kannel
12 2008
12
🐜
🦁 Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
M. Pencina, R. B. D' Agostino, R. B. D' Agostino, R. Vasan
12 2008
12
🦁
🐜 Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures
8 auth. E. Steyerberg, A. Vickers, N. Cook, T. Gerds, M. Gonen, N. Obuchowski, ... M. Pencina, M. Kattan
11 2010
11
🐜
🐜 Vitamin D Deficiency and Risk of Cardiovascular Disease
10 auth. Thomas J. Wang, M. Pencina, S. Booth, P. Jacques, E. Ingelsson, Katherine J. Lanier, ... E. Benjamin, R. D'Agostino, M. Wolf, R. Vasan
11 2008
11
🐜
🦁 Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
M. Pencina, R. D'Agostino, E. Steyerberg
11 2011
11
🦁
🐜 Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
19 auth. Jennifer B. Green, M. A. Bethel, P. Armstrong, J. Buse, S. Engel, Jyotsna Garg, R. Josse, K. Kaufman, J. Koglin, S. Korn, ... J. Lachin, Darren K Mcguire, M. Pencina, E. Standl, P. Stein, S. Suryawanshi, F. Van de Werf, E. Peterson, R. Holman
11 2015
11
🐜
🐜 Arterial Stiffness and Cardiovascular Events: The Framingham Heart Study
9 auth. G. Mitchell, Shih-Jen Hwang, R. Vasan, M. Larson, M. Pencina, N. Hamburg, ... J. Vita, D. Levy, E. Benjamin
10 2010
10
🐜
🦁 Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation
M. Pencina, R. D'Agostino
10 2004
10
🦁
🐬 On the C‐statistics for evaluating overall adequacy of risk prediction procedures with censored survival data
H. Uno, T. Cai, M. Pencina, R. D’Agostino, Lee-Jen Wei
10 2011
10
🐬
🐜 One-year cardiovascular event rates in outpatients with atherothrombosis.
12 auth. P. Steg, Deepak L. Bhatt, P. Wilson, R. D'Agostino, E. Ohman, J. RΓΆther, ... C. Liau, A. Hirsch, J. Mas, Y. Ikeda, M. Pencina, S. Goto
10 2007
10
🐜
🐜 Diagnostic accuracy of fractional flow reserve from anatomic CT angiography.
21 auth. J. Min, J. Leipsic, M. Pencina, D. Berman, B. Koo, Carl-Edward Van Mieghem, A. Erglis, F. Lin, A. Dunning, Patricia Apruzzese, ... M. Budoff, Jason H. Cole, F. Jaffer, M. Leon, M. Leon, J. Malpeso, G. Mancini, Seung‐Jung Park, R. Schwartz, L. Shaw, L. Mauri
10 2012
10
🐜
🐜 Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study
16 auth. R. Schnabel, L. Sullivan, D. Levy, M. Pencina, J. Massaro, R. D'Agostino, C. Newton‐Cheh, J. Yamamoto, J. Magnani, T. Tadros, ... W. Kannel, Thomas J. Wang, P. Ellinor, P. Wolf, R. Vasan, E. Benjamin
9 2009
9
🐜
🐜 Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial
19 auth. J. Rosenstock, V. Perkovic, O. Johansen, M. Cooper, S. Kahn, N. Marx, J. Alexander, M. Pencina, R. Toto, C. Wanner, ... B. Zinman, H. Woerle, David Baanstra, E. Pfarr, S. Schnaidt, T. Meinicke, J. George, M. von Eynatten, D. McGuire
9 2019
9
🐜
🐜 Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy
27 auth. Raymond H Chan, B. Maron, I. Olivotto, M. Pencina, G. Assenza, Tammy S. Haas, J. Lesser, C. Gruner, A. Crean, H. Rakowski, J. Udelson, E. Rowin, M. Lombardi, F. Cecchi, B. Tomberli, ... P. Spirito, Francesco Formisano, E. Biagini, C. Rapezzi, C. D. De Cecco, C. Autore, E. Cook, S. Hong, C. Gibson, W. Manning, E. Appelbaum, M. Maron
9 2014
9
🐜
🦁 Predicting the 30-Year Risk of Cardiovascular Disease: The Framingham Heart Study
M. Pencina, R. D'Agostino, M. Larson, J. Massaro, R. Vasan
9 2009
9
🦁